Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TC | 0.700 | CausalMutation | CLINVAR | Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. | 20141835 | 2010 |
|||||||
|
|
TC | 0.700 | CausalMutation | CLINVAR | Determinants of BRAF mutations in primary melanomas. | 14679157 | 2003 |
|||||||
|
|
TC | 0.700 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Genetic predictors of MEK dependence in non-small cell lung cancer. | 19010912 | 2008 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Missense mutations of the BRAF gene in human lung adenocarcinoma. | 12460919 | 2002 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. | 21483012 | 2011 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. | 22649091 | 2012 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. | 23833300 | 2013 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. | 19238210 | 2009 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Missense mutations of the BRAF gene in human lung adenocarcinoma. | 12460919 | 2002 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Genetic predictors of MEK dependence in non-small cell lung cancer. | 19010912 | 2008 |
|||||||
|
|
GA | 0.700 | GeneticVariation | CLINVAR | Analysis of BRAF mutation in primary and metastatic melanoma. | 16096377 | 2005 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. | 19238210 | 2009 |
|||||||
|
|
GA | 0.700 | GeneticVariation | CLINVAR | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | 25157968 | 2014 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Mutations of the BRAF gene in human cancer. | 12068308 | 2002 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib. | 22649091 | 2012 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. | 21483012 | 2011 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. | 23833300 | 2013 |
|||||||
|
|
AA | 0.700 | CausalMutation | CLINVAR | Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib. | 24035431 | 2013 |
|||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.900 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.800 | CausalMutation | CLINVAR | Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. | 22608338 | 2012 |